PURPOSE To provide evidence-based recommendations to health care providers on
integrative approaches to managing anxiety and depression symptoms in adults living with …

While overall outcomes for cancer care have improved considerably in the United States
over the past century, as evidenced by decreases in incidence and mortality of certain …

Abstract Representation of humans from diverse backgrounds in the drug development
process is key to advancing health equity, and while clinical trial design has recently made …

Whereas traditional oncology clinical trial endpoints remain key for assessing novel
treatments, capturing patients' functional status is increasingly recognized as an important …

Despite much vaunted progress in cancer therapeutics and diagnostics, outcomes for many
groups of non-White patients with cancer remain worse than those for their White …

Introduction Databases used for clinical interpretation in oncology rely on genetic data
derived primarily from patients of European ancestry, leading to biases in cancer genetics …

Background Breast cancer (BC) affects racial and ethnic groups differently, leading to
disparities in clinical presentation and outcomes. It is unclear how Hispanic ethnicity affects …

Systematic multiomic analysis has revealed ancestry-dependent molecular alterations, but
their impact on the efficacy of anticancer treatment is yet largely unknown. In this study, we …